News
A 58-year-old male patient presents with a five-year history of suprapubic pain, nocturia, dysuria, recurrent urinary tract ...
Higher body fat, especially android fat, BMI, and waist size, is linked to stress urinary incontinence in midlife women, but ...
The FDA designates the TOBY Test as a breakthrough device, revolutionizing bladder cancer detection with a non-invasive, ...
Bladder cancer, often misunderstood, affects both men and women, not just the elderly. While smoking is a significant risk factor, genetics and chemic ...
How does peeing ‘just in case’ affect bladder health? To understand why proactive voiding can be harmful, it helps to know how the bladder works.
In a medical milestone, UCLA surgeons completed the world's first in-human bladder transplant. Oscar Larrainzar had been struggling after having most of his bladder removed due to a tumor.
Patients with tumors in the trigone and urethra were more likely to experience recurrence and cancer-specific death after radical cystectomy than patients with tumor only in the bladder walls.
“We believe Trigone’s novel intravesicular sustained-release formulation could enable NDV-01 to be a first-line therapy for non-muscle invasive bladder cancer, supported by several ...
Relmada Therapeutics announced a licensing agreement for NDV-01, a new treatment for non-muscle invasive bladder cancer. Phase 2 data expected in April 2025. Quiver AI Summary Relmada Therapeutics ...
Relmada Therapeutics Licenses Phase 2 Bladder Cancer Candidate, NDV-01, from Trigone Pharma, Ltd.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results